Related references
Note: Only part of the references are listed.Statins and the Risk of Colorectal Carcinoma: A Nested Case-Control Study in Veterans With Diabetes
Christine Hachem et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Statins and cancer risk
Igor Karp et al.
AMERICAN JOURNAL OF MEDICINE (2008)
Cholesterol modulates cellular TGF-β responsiveness by altering TGF-β binding to TGF-β receptors
Chun-Lin Chen et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
The association between statins and cancer incidence in a veterans population
Wildon R. Farwell et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials
Giovanni F. M. Strippoli et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Screening statins for possible carcinogenic risk: up to 9 years of follow-up of 361 859 recipients
Gary D. Friedman et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2008)
Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack - The stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial
Pierre Amarenco et al.
STROKE (2007)
Long-term follow-up of the West of Scotland Coronary Prevention Study
Ian Ford et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Statins reduce the risk of lung cancer in humans* - A large case-control study of US veterans
Vikas Khurana et al.
CHEST (2007)
Statin use and the risk of 10 cancers
Patricia F. Coogan et al.
EPIDEMIOLOGY (2007)
Statin use and risk of colorectal cancer
Patricia F. Coogan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Statin drugs and risk of advanced prostate cancer
Elizabeth A. Platz et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Statin use and breast cancer: Prospective results from the Women's Health Initiative
JA Cauley et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Statins and cancer risk - A meta-analysis
KM Dale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Anti-angiogenic and anti-inflammatory effects of statins:: Relevance to anti-cancer therapy
J Dulak et al.
CURRENT CANCER DRUG TARGETS (2005)
High-dose atorvastatin vs usual dose simvastatin for secondary prevention after myocardial infarction - The IDEAL study: A randomized controlled trial
TR Pedersen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Serum lipids, lipid-lowering drugs, and the risk of breast cancer
AH Eliassen et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Statins and prostate cancer risk: A case-control study
J Shannon et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis
C Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The effect of statins on serum prostate specific antigen levels in a cohort of airline pilots: A preliminary report
MS Cyrus-David et al.
JOURNAL OF UROLOGY (2005)
Statins and the risk of colorectal cancer
JN Poynter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Statins activate the mitochondrial pathway of apoptosis in human lymphoblasts and myeloma cells
P Cafforio et al.
CARCINOGENESIS (2005)
Cancer risk among statin users: A population-based cohort study
S Friis et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
JC LaRosa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Statins prevent oxidized low-density lipoprotein- and lysophosphatidylcholine-induced proliferation of human endothelial cells
CA Schaefer et al.
VASCULAR PHARMACOLOGY (2004)
Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure
TB Horwich et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Statin use and cancer risk in the General Practice Research Database
JA Kaye et al.
BRITISH JOURNAL OF CANCER (2004)
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)
TE Strandberg et al.
LANCET (2004)
The risk of cancer in users of statins
MR Graaf et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
p21-dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases
C Ukomadu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells
M Frick et al.
ATHEROSCLEROSIS (2003)
Effect of fluvastatin on cardiac outcomes in renal transplant recipients:: a multicentre, randomised, placebo-controlled trial
H Holdaas et al.
LANCET (2003)
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care - The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT-LLT)
CD Furberg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
J Shepherd et al.
LANCET (2002)
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention - A randomized controlled trial
PWJC Serruys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Statins have biphasic effects on angiogenesis
M Weis et al.
CIRCULATION (2002)
Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins
A Brouet et al.
CIRCULATION RESEARCH (2001)
Blocking oncogenic Ras signaling for cancer therapy
AA Adjei
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
G Weitz-Schmidt et al.
NATURE MEDICINE (2001)
Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
K Fassbender et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia
J Musial et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2001)
3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and the risk of cancer -: A nested case-control study
L Blais et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Oral statins and increased bone-mineral density in postmenopausal women
CJ Edwards et al.
LANCET (2000)
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
Y Kureishi et al.
NATURE MEDICINE (2000)
Suppression of invasion and MMP-9 expression in NIH 3T3 and v-H-Ras 3T3 fibroblasts by lovastatin through inhibition of gas isoprenylation
IK Wang et al.
ONCOLOGY (2000)
Share Paper
